LENZ Therapeutics, Inc.
LENZ
$28.00
$0.692.53%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -11.99% | -2.00% | -15.55% | -23.86% | 0.38% |
| Total Depreciation and Amortization | 557.89% | -47.22% | 44.00% | 150.00% | -44.44% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 37.46% | 30.21% | 577.03% | -73.32% | 30.41% |
| Change in Net Operating Assets | 270.94% | 148.10% | -189.24% | 375.41% | 80.51% |
| Cash from Operations | 25.37% | 28.29% | -76.79% | 14.20% | 33.01% |
| Capital Expenditure | -82.92% | -118.18% | 26.17% | 19.89% | -39.85% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2,137.93% | -100.92% | 262.19% | 81.12% | 36.86% |
| Cash from Investing | -946.62% | -102.19% | 259.23% | 80.94% | 36.76% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -97.74% | 60,100.00% | -16.98% | -99.82% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 100.00% | 99.35% |
| Cash from Financing | -97.74% | 60,100.00% | -16.98% | -99.82% | 1,495.32% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -184.60% | 405.06% | 113.81% | 51.41% | 63.04% |